Madenco Biosciences is a global consumer health company
- Focused on commercializing scientifically validated pharmaceutical products through development, licensing and acquisition
- Subsidiary of Quest PharmaTech Inc.
- focus on dermatology and wound healing applications
- License and Distribution- Bioceltran Protein Transduction Domain (PTD) technology (also known as SP Technology)
- Diversified Product Pipeline
- Development of product utilizing PTD technology for sexual health/dysfunction
- Development of product utilizing PTD technology combined with FGF1 for wound healing/diabetic ulcers